Emmaus Life Sciences (EMMA) Short Interest Ratio & Short Volume $0.01 0.00 (-0.72%) As of 07/3/2025 11:51 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Emmaus Life Sciences Short Interest DataEmmaus Life Sciences (EMMA) has a short interest of 33,200 shares, representing 0.08% of the float (the number of shares available for trading by the public). This marks a 4,642.86% increase in short interest from the previous month. The short interest ratio (days to cover) is 9.2, indicating that it would take 9.2 days of the average trading volume of 24,338 shares to cover all short positions.Current Short Interest33,200 sharesPrevious Short Interest700 sharesChange Vs. Previous Month+4,642.86%Dollar Volume Sold Short$564.40Short Interest Ratio9.2 Days to CoverLast Record DateJune 15, 2025Outstanding Shares63,866,000 sharesShort Percent of Float0.08%Today's Trading Volume500 sharesAverage Trading Volume24,338 sharesToday's Volume Vs. Average2% Short Selling Emmaus Life Sciences? Sign up to receive the latest short interest report for Emmaus Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEMMA Short Interest Over TimeEMMA Days to Cover Over TimeEMMA Percentage of Float Shorted Over Time Emmaus Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202533,200 shares $564.40 +4,642.9%0.1%9.2 $0.02 5/31/2025700 shares $13.93 No Change0.0%0 $0.02 5/15/2025700 shares $8.40 -50.0%0.0%0 $0.01 4/30/20251,400 shares $23.10 -75.0%N/A0.4 $0.02 4/15/20255,600 shares $89.60 +16.7%0.0%0.7 $0.02 3/31/20254,800 shares $82.08 -25.0%0.0%0.2 $0.02 3/15/20256,400 shares $175.36 +30.6%0.0%0.1 $0.03 2/28/20254,900 shares $85.75 -51.5%0.0%0 $0.02 2/15/202510,100 shares $451.47 -53.5%0.0%0.1 $0.04 1/31/202521,700 shares $353.71 +47.6%N/A1.1 $0.02 Get the Latest News and Ratings for EMMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/202514,700 shares $205.80 +2,000.0%N/A0.6 $0.01 12/31/2024700 shares $5.95 No ChangeN/A0 $0.01 12/15/2024700 shares $4.69 -22.2%N/A0 $0.01 11/30/2024900 shares $26.91 -10.0%N/A0 $0.03 11/15/20241,000 shares $36.50 +42.9%N/A0 $0.04 10/31/2024700 shares $24.50 No ChangeN/A0 $0.04 10/15/2024700 shares $24.50 No ChangeN/A0 $0.04 9/30/2024700 shares $20.86 No ChangeN/A0 $0.03 9/15/2024700 shares $26.25 No ChangeN/A0 $0.04 8/31/2024700 shares $0.21 No ChangeN/A1 $0.00 8/15/2024700 shares $2.10 No ChangeN/A0 $0.00 7/31/2024700 shares $1.75 No ChangeN/A0.1 $0.00 7/15/2024700 shares $49.91 No ChangeN/A0 $0.07 6/30/2024700 shares $70.70 No ChangeN/A0 $0.10 6/15/2024700 shares $64.01 No ChangeN/A0.1 $0.09 5/31/2024700 shares $64.40 No ChangeN/A0.1 $0.09 5/15/2024700 shares $72.10 No ChangeN/A0.3 $0.10 4/30/2024700 shares $70.00 No ChangeN/A0.1 $0.10 4/15/2024700 shares $73.50 -12.5%N/A0.9 $0.11 3/31/2024800 shares $84.00 -89.5%N/A0.1 $0.11 3/15/20247,600 shares $768.36 +33.3%N/A0.4 $0.10 2/29/20245,700 shares $676.02 +714.3%N/A0.1 $0.12 2/15/2024700 shares $67.27 -93.6%N/A0.1 $0.10 1/15/20244,100 shares $369.00 -6.8%N/A0.4 $0.09 12/31/20234,400 shares $440.33 +450.0%N/A0 $0.10 12/15/2023800 shares $88.00 -50.0%N/A0.1 $0.11 11/30/20231,600 shares $208.00 +128.6%N/A0 $0.13 11/15/2023700 shares $77.00 No ChangeN/A0 $0.11 10/31/2023700 shares $84.00 No ChangeN/A0 $0.12 10/15/2023700 shares $105.00 -22.2%N/A0 $0.15Trump's ticking time bomb (Ad)A looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House document might be the real trigger. One market expert who predicted major collapses in 2008 is now warning of a second, far more explosive directive tied to America’s most vital resource. If he’s right, it could set off a financial shock unlike anything we’ve seen in decades.See his urgent July 9th forecast here 9/30/2023900 shares $112.50 No ChangeN/A0.5 $0.13 9/15/2023900 shares $117.00 +28.6%N/A0.1 $0.13 8/31/2023700 shares $105.88 -41.7%N/A0 $0.15 8/15/20231,200 shares $252.00 No ChangeN/A0.4 $0.21 7/31/20231,200 shares $264.00 +71.4%N/A0.2 $0.22 7/15/2023700 shares $168.35 -50.0%N/A0.1 $0.24 6/30/20231,400 shares $322.00 -68.9%N/A0.2 $0.23 6/15/20234,500 shares $1.22 thousand -65.1%N/A0.8 $0.27 5/31/202312,900 shares $4.13 thousand +1,742.9%N/A0.5 $0.32 5/15/2023700 shares $224.00 -83.7%N/A0 $0.32 4/30/20234,300 shares $1.35 thousand -4.4%N/A0.2 $0.32 4/15/20234,500 shares $1.49 thousand +50.0%N/A0.1 $0.33 3/31/20233,000 shares $907.50 +328.6%N/A0.3 $0.30 3/15/2023700 shares $245.00 No ChangeN/A0.1 $0.35 2/28/2023700 shares $266.00 -91.9%N/A0.1 $0.38 2/15/20238,600 shares $4.04 thousand +244.0%N/A0.2 $0.47 1/31/20232,500 shares $999.50 +257.1%N/A0 $0.40 1/15/2023700 shares $203.00 No ChangeN/A0 $0.29 12/30/2022700 shares $182.21 -87.7%N/A0 $0.26 12/15/20225,700 shares $1.88 thousand +714.3%N/A0.2 $0.33 11/30/2022700 shares $271.60 -86.0%N/A0 $0.39 11/15/20225,000 shares $1.50 thousand +72.4%N/A0.2 $0.30 10/31/20222,900 shares $1.31 thousand +314.3%N/A0 $0.45 10/15/2022700 shares $126.00 No ChangeN/A0 $0.18 9/30/2022700 shares $119.00 -53.3%N/A0 $0.17 9/15/20221,500 shares $450.00 No ChangeN/A0.2 $0.30 8/31/20221,500 shares $540.00 +87.5%N/A0.1 $0.36 8/15/2022800 shares $296.00 +14.3%N/A0 $0.37 7/31/2022700 shares $245.00 No ChangeN/A0 $0.35 7/15/2022700 shares $280.00 No ChangeN/A0.1 $0.40 6/30/2022700 shares $315.00 No ChangeN/A0.1 $0.45 6/15/2022700 shares $252.00 -66.7%N/A0 $0.36 5/31/20222,100 shares $840.00 -83.5%N/A0 $0.40 5/15/202212,700 shares $3.19 thousand +693.8%N/A0.2 $0.25 4/30/20221,600 shares $1.28 thousand -5.9%N/A0.2 $0.80 4/15/20221,700 shares $1.29 thousand +142.9%N/A0 $0.76 3/31/2022700 shares $700.00 -12.5%N/A0 $1.00 3/15/2022800 shares $1.09 thousand No ChangeN/A0.1 $1.36 2/28/2022800 shares $1.16 thousand -33.3%N/A0 $1.45 2/15/20221,200 shares $1.74 thousand +71.4%N/A0 $1.45 1/31/2022700 shares $980.00 -12.5%N/A0 $1.40 1/15/2022800 shares $1.15 thousand +14.3%N/A0 $1.44 12/31/2021700 shares $1.17 thousand No ChangeN/A0 $1.67 12/15/2021700 shares $1.07 thousand -50.0%N/A0 $1.53 11/30/20211,400 shares $3.01 thousand -57.6%N/A0 $2.15 11/15/20213,300 shares $4.03 thousand +230.0%N/A0.1 $1.22 10/29/20211,000 shares $1.43 thousand -23.1%N/A0.1 $1.43 10/15/20211,300 shares $2.11 thousand No ChangeN/A0.1 $1.62 9/30/20211,300 shares $2.08 thousand +44.4%N/A0.1 $1.60 9/15/2021900 shares $1.30 thousand -79.6%N/A0 $1.44Trump's ticking time bomb (Ad)A looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House document might be the real trigger. One market expert who predicted major collapses in 2008 is now warning of a second, far more explosive directive tied to America’s most vital resource. If he’s right, it could set off a financial shock unlike anything we’ve seen in decades.See his urgent July 9th forecast here 8/31/20214,400 shares $6.82 thousand +46.7%N/A0.3 $1.55 8/13/20213,000 shares $4.65 thousand -37.5%N/A0.3 $1.55 7/30/20214,800 shares $7.20 thousand +433.3%N/A0.4 $1.50 7/15/2021900 shares $1.35 thousand No ChangeN/A0.1 $1.50 6/30/2021900 shares $1.28 thousand -70.0%N/A0.1 $1.42 6/15/20213,000 shares $4.80 thousand +150.0%N/A0.3 $1.60 5/28/20211,200 shares $1.94 thousand +33.3%N/A0.2 $1.62 5/14/2021900 shares $1.31 thousand -74.3%N/A0 $1.45 4/30/20213,500 shares $4.52 thousand +288.9%N/A0.1 $1.29 4/15/2021900 shares $1.22 thousand +28.6%N/A0.1 $1.35 3/31/2021700 shares $1.20 thousand No ChangeN/A0 $1.71 3/15/2021700 shares $1.05 thousand -50.0%N/A0 $1.50 2/26/20211,400 shares $1.97 thousand -33.3%N/A0 $1.41 2/12/20212,100 shares $3.51 thousand -12.5%N/A0 $1.67 1/29/20212,400 shares $2.93 thousand -11.1%N/A0.8 $1.22 1/15/2021700 shares $861.00 -68.2%N/A0 $1.23 12/31/2020700 shares $805.00 No ChangeN/A0 $1.15 12/15/2020700 shares $770.00 -68.2%N/A0 $1.10 11/30/20202,200 shares $2.64 thousand -31.3%N/A0.1 $1.20 11/15/20203,200 shares $2.72 thousand +3.2%N/A0.1 $0.85 10/30/20203,100 shares $2.54 thousand -75.2%N/A0.2 $0.82 10/15/202012,500 shares $9.40 thousand +468.2%N/A0.3 $0.75 9/30/20202,200 shares $2.13 thousand +144.4%N/A0.1 $0.97 9/15/2020900 shares $1.04 thousand -40.0%N/A0 $1.16 EMMA Short Interest - Frequently Asked Questions What is Emmaus Life Sciences' current short interest? Short interest is the volume of Emmaus Life Sciences shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 33,200 shares of EMMA short. 0.08% of Emmaus Life Sciences' shares are currently sold short. Learn More on Emmaus Life Sciences' current short interest. What is a good short interest ratio for Emmaus Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EMMA shares currently have a short interest ratio of 9.0. Learn More on Emmaus Life Sciences's short interest ratio. What is a good short interest percentage for Emmaus Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.08% of Emmaus Life Sciences' floating shares are currently sold short. Is Emmaus Life Sciences' short interest increasing or decreasing? Emmaus Life Sciences saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 33,200 shares, an increase of 4,642.9% from the previous total of 700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Emmaus Life Sciences' short interest compare to its competitors? 0.08% of Emmaus Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Emmaus Life Sciences: Clearmind Medicine Inc. (4.21%), Can-Fite BioPharma Ltd. (0.82%), Evoke Pharma, Inc. (1.26%), Sonnet BioTherapeutics Holdings, Inc. (1.94%), Theriva Biologics, Inc. (2.78%), Tharimmune, Inc. (0.95%), Organovo Holdings, Inc. (4.32%), Evaxion A/S - Sponsored ADR (4.44%), Lipella Pharmaceuticals Inc. (2.01%), SciSparc Ltd. (1.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Emmaus Life Sciences stock? Short selling EMMA is an investing strategy that aims to generate trading profit from Emmaus Life Sciences as its price is falling. EMMA shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Emmaus Life Sciences? A short squeeze for Emmaus Life Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EMMA, which in turn drives the price of the stock up even further. How often is Emmaus Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EMMA, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Clearmind Medicine Short Squeeze Can-Fite BioPharma Short Squeeze Evoke Pharma Short Squeeze Sonnet BioTherapeutics Short Squeeze Theriva Biologics Short Squeeze Tharimmune Short Squeeze Organovo Short Squeeze Evaxion A/S Short Squeeze Lipella Pharmaceuticals Short Squeeze SciSparc Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:EMMA) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s BIGGEST setup yet.After another undefeated quarter, “Market Wizard” Larry Benedict is sounding the alarm on a $194 trillion mark...Brownstone Research | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emmaus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Emmaus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EMMA Stock Alerts